Screener
Xeris Biopharma Holdings, Inc. XERS Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s net debt?
- Xeris Biopharma Holdings, Inc. (XERS) reported net debt of $167.7M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s net debt changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s net debt decreased by 15.3% year-over-year, from $197.94M to $167.7M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s net debt?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s net debt has grown at a 24.4% compound annual growth rate (CAGR), from $49.42M to $147.06M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Xeris Biopharma Holdings, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude